ABIOMED, Inc., is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. In April 2014, the Company acquired exclusive license from collaboration partner Opsens Inc. In July 2014, Abiomed Inc acquired ECP Entwicklungsgesellschaft mbH (ECP), medical device company based in Berlin, Germany, and AIS GmbH Aachen Innovative Solutions through ECP.